Waterford, CT, United States of America

Russell J Shine


Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1996-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Russell J Shine

Introduction

Russell J Shine is a notable inventor based in Waterford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address psychotic diseases. With a total of three patents to his name, Shine's work has had a meaningful impact on medical science.

Latest Patents

One of Shine's latest patents is focused on mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one, commonly known as ziprasidone. This invention includes the preparation and use of these salts as a dopamine D2 antagonist. The patent outlines pharmaceutical compositions containing ziprasidone mesylate dihydrates and methods for administering these compounds to treat psychotic diseases. Another patent involves the process for steroidal peracyl glycosides, showcasing his diverse expertise in pharmaceutical innovations.

Career Highlights

Russell J Shine is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.

Collaborations

Some of Shine's notable coworkers include Frank R Busch and John F Lambert. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Russell J Shine's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the treatment of psychotic diseases, showcasing the importance of innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…